Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Puerto Rico for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Puerto Rico only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Puerto Rico (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Cdt Gmsp, Inc (NPI 1790750529)

Key Findings

Field	Value
Entity Type	Organization
Organization	Cdt Gmsp, Inc
Address	B7 Calle Santa Cruz
City	Bayamon
State	PR
ZIP	00961
Taxonomy	Federally Qualified Health Center (FQHC)
NPI Enumerated	February 23, 2006

Payer Source	Total Paid
Medicaid	$4.6M
Medicare	$0

CDT GMSP, INC reports $4.6M in lifetime Medicaid revenue and has no Medicare billing on file, making its financial footprint effectively single‑payer Medicaid for the available data. The provider’s NPI was enumerated 2006-02-23 (~20 years ago), indicating a long tenure as an active FQHC in BAYAMON, PR.

Revenue concentration in Medicaid is notable: the precomputed top three Medicaid codes (87426, 84443, 87804) account for 36.4% of the provider’s total Medicaid revenue, signaling a relatively concentrated revenue mix around a handful of high-volume lab services. Those top codes individually include 87426 ($702.7K revenue, 16.1%), 84443 ($461.4K revenue, 10.6%), and 87804 ($427.8K revenue, 9.8%), each contributing materially to the $4.6M Medicaid total.

The code mix is heavily laboratory- and screening-oriented, consistent with an FQHC operating high-volume primary-care and public-health testing services: 87426 and 87804 are SARS‑CoV‑2 and influenza immunoassays, 84443 is TSH testing, and other frequent codes include lipid panel (80061), CMP (80053), CBC (85025), A1C (83036), and vitamin D (82306). This profile suggests routine chronic disease monitoring combined with broad infectious‑disease screening and point-of-care/clinic-based lab throughput.

CDT GMSP is a dominant in-state performer on several individual test codes. For example, 87804 ranks #2 of 318 providers in-state (100th percentile; extreme outlier) for influenza immunoassays, 87426 ranks #9 of 649 (99th percentile; extreme outlier) for the SARS‑CoV‑2 immunoassay, and 86701 ranks #2 of 396 (100th percentile; extreme outlier) for HIV antibody testing — together these ranks indicate an unusually large testing volume relative to in-state peers for key infectious-disease screens.

Several additional lab codes show notably above-typical or extreme volumes, reinforcing the laboratory-focused business line: 80061 (29.3K claims, $409.8K revenue) and 80053 (25.8K claims, $283.4K revenue) are both in the 98–99th percentile statewide, while fecal immunochemical testing 82274 (9.9K claims, $178.5K revenue) and routine urinalysis 81000 (32.4K claims, $97.2K revenue) are labeled extreme outliers within the state. These patterns point to scale in routine screening and diagnostics beyond typical peer activity.

The provider’s approach to COVID testing appears skewed toward immunoassays and antibody testing rather than high volumes of NAAT/RT‑PCR specimen testing: 87426 ($702.7K) and 86328 ($51.1K) are present at high relative volumes, while the NAAT code 87635 ($122.1K revenue) ranks #42 of 366 (89th percentile; typical, unremarkable volume). This suggests substantial rapid/antigen and serologic testing activity compared with more moderate molecular testing volumes.

Not all codes mirror the extreme outlier pattern: some entries are in typical or lower-percentile ranges, for example G2023 (specimen collection for SARS‑CoV‑2) ranks #355 of 587 in-state (39th percentile; typical, unremarkable volume) and 87635 (SARS‑CoV‑2 NAAT) sits at the 89th percentile (typical, unremarkable volume). These mixed percentiles suggest CDT GMSP concentrates revenue on performed analyses and panels rather than consistently capturing higher relative volume across every ancillary collection or molecular test code.

From a payer-mix and competitive perspective, the absence of Medicare claims coupled with $4.6M in Medicaid revenue and multiple state-level extreme outlier ranks implies CDT GMSP operates as a Medicaid-centric FQHC with outsized lab and screening throughput in Puerto Rico. Analysts evaluating network capacity or contracting should view this entity as a major in-state diagnostic and preventive-services provider for Medicaid populations, especially for infectious-disease and routine laboratory testing.

Medicaid: Complete Services Breakdown

Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.

74 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
87426	The lab analyst performs an immunoassay to qualitatively or semiquantitatively evaluate the patient blood specimen for antigens of severe acute respiratory syndrome coronavirus such as SARS–CoV–2,…	16,730	$40	$702.7K
84443	The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the…	24,280	$20	$461.4K
87804	The analyst performs an immunoassay with direct optical, meaning visual, observation to detect influenza, also called flu, in a patient sample, typically a throat or nasal swab or nasal washings.	30,560	$10	$427.8K
80061	The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood.	29,270	$10	$409.8K
80053	The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel.	25,760	$10	$283.4K
85025	A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a…	34,590	$10	$276.7K
87491	The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique.	6,080	$40	$243.1K
87591	The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique.	6,040	$40	$241.7K
82274	The lab analyst uses an immunoassay method to perform a test for hidden blood in a fecal specimen that the patient collects from three consecutive bowel movements or that the clinician acquires…	9,920	$20	$178.5K
86701	The lab analyst performs an immunoassay to evaluate the patient’s serum for antibodies to HIV 1, human immunodeficiency virus 1.	14,370	$10	$143.7K

Showing 1–10 of 74

Medicaid: Competitive Analysis & Benchmarks

How this provider's Medicaid billing volume and revenue compare to other Puerto Rico providers billing the same CPT/HCPCS codes.

Claims Volume vs. Puerto Rico Distribution

Cdt Gmsp, Inc — 17 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Puerto Rico

Full comparison — all codes billed, vs. Puerto Rico median

74 rows

CPT/HCPCS Code	Description	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
87426	The lab analyst performs an immunoassay to qualitatively or semiquantitatively evaluate the patient blood specimen for antigens of severe acute respiratory syndrome coronavirus such as SARS–CoV–2,…	9	650	1,260	$40	$93.7K
84443	The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the…	12	770	2,520	$20	$65.5K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	355	590	1,440	$20	$65.4K
87635	Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus…	42	370	370	$50	$63.3K
80061	The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood.	13	810	2,350	$10	$52.7K
87591	The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique.	13	290	170	$30	$43.8K
87491	The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique.	13	310	190	$30	$43.1K
80053	The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel.	14	790	2,360	$10	$41.9K
85025	A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a…	14	850	3,250	$10	$40.5K
82306	The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced…	47	650	630	$30	$35.8K

Showing 1–10 of 74

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Edwin Baez Montalvo	PR	Obstetrics Physician	$0	$644.3K
Felix Del Rio	PR	Cardiovascular Disease Physician	$16.8K	$185K
Raul Rios Mollineda	PR	Pulmonary Disease Physician	$37.5K	$2.5K
Luis Rivera-ramos	PR	Neurology Physician	$29.8K	$0
Horacio Daubon Del Valle	PR	Neurology Physician	$21.1K	$0
Emmanuel Bobe Rosario	PR	General Practice Physician	$12.4K	$0
Domingo Perez	PR	Cardiovascular Disease Physician	$9.1K	$0

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Nazareno Enterprises And Services LLC	PR	Prosthetic/Orthotic Supplier	$0	$23.8M
Centro Medico Del Turabo, Inc.	PR	Home Infusion Therapy Pharmacy	$0	$3.9M
Djm Imaging Center LLC	PR	Radiology Clinic/Center	$0	$3.6M
Cdt Centro De Servicios Medicos Integrados Inc.	PR	Clinical Medical Laboratory	$0	$2.3M
Cdt G.m,s.p., Inc Radiologia	PR	Federally Qualified Health Center (FQHC)	$0	$1.7M
Pro-health Clinical Services LLC	PR	Endocrinology, Diabetes & Metabolism Physician	$0	$1.6M
Edilberto Martinez	PR	Maternal & Fetal Medicine Physician	$0	$1.4M
Laboratorio Teresita	PR	Clinical Medical Laboratory	$4.8K	$1.3M
Dr Joaquin Balaguer Group Psc	PR	Podiatrist	$0	$1.2M
San Pablo Pathology Group Inc.	PR	Anatomic Pathology Physician	$0	$1.1M

Cdt Gmsp, Inc — Billing Profile & Reimbursement Data

Sign up for Cdt Gmsp, Inc — Billing Profile & Reimbursement Data policy alerts

Cdt Gmsp, Inc — Billing Profile & Reimbursement Data

Sign up for Cdt Gmsp, Inc — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicaid: Total Revenue Breakdown by CPT/HCPCS Code

Medicaid: Complete Services Breakdown

Medicaid: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References